Background. As diabetes insipidus in brain-dead organ donors leads to hypovolaemia, hyponatraemia, and hypotension, desmopressin is recommended for treatment of diabetes insipidus. As its effect on early renal allograft function remains unclear, we conducted a study to evaluate the effect of desmopressin on renalgraft survival. Methods. We report the results of a prospective study in 41 brain-dead organ donors (mean age 45 ± 12 years) with diabetes insipidus, who were treated either with adequate fluid substitution and bolus application of desmopressin (desmopressin group; n = 22) or with volume substitution alone (control group; n=\9). Donors as well as recipients of both groups were well matched with respect to age, sex, dopamine dosage, serum electrolytes, cold ischaemic time, HLA match, number of prior transplantations, and current cytotoxic antibodies. Early renal allograft function was evaluated in 71 recipients (mean age 48 ±14 years) within 3 days after transplantation. Results. Overall, primary non-function was observed in 26 (36.6%) of 71 recipients. The rate of primary non-function was significantly higher in the desmopressin group compared to the control group (desmopressin group 48.6%; control group 23.5%; />=0.028). Conclusion. The use of desmopressin during organ procurement is associated with a higher rate of primary non-function of renal allografts.
Introduction
Diabetes insipidus is observed in 30-90% of all organ donors and may lead to severe metabolic and haemo- dynamic disturbances during procurement [ 1 -4] . Thus, desmopressin substitution is recommended for the treatment of diabetes insipidus to avoid electrolyte and fluid disturbances. Beside its antidiuretic effect desmopressin may also increase mean arterial blood pressure by increasing total peripheral resistance through vasoconstriction [1, 2] . Whereas the vasoconstrictive effects of catecholamines are adversely related to allograft outcome, data about the influence of desmopressin on renal allograft outcome are rare [5] [6] [7] [8] . As prospectively collected data are lacking, we aimed to evaluate prospectively the effect of desmopressin substitution during organ donor management on early renal allograft outcome.
Methods
Forty-one brain-dead organ donors (mean age 48 ± 14 years; range 24-69), who developed diabetes insipidus, were included in a prospective non-randomized study. Donors were matched with respect to age, sex and dopamine dosage during procurement. Diabetes insipidus was defined if hypotonic polyuria (urine output >4ml/kg/min; urinary specific gravity < 1.005) or hypernatraemia (serum sodium >145mmol/l) and a disturbance in osmol-regulation such that plasma osmolality is greater than 300 mmol/kg and urine osmolality is less than 300 mmol/kg are evident. All brain-dead organ donors were ventilated mechanically. Respiratory pattern and oxygen content were adjusted to maintain a pH value of 7.4±0.05, a pCO 2 of 35±5mmHg, and a pO 2 of 90 ± 10 mmHg. Arterial blood pressure (ABP), central venous pressure (CVP), and body temperature were measured continuously. Urine output, serum electrolytes, serum creatinine and blood gases were determined hourly. According to treatment of diabetes insipidus, brain-dead organ donors were divided into two groups: whereas one group (desmopressin group) received adequate fluid substitution combined with intravenous bolus application of desmopressin (2 ug) every 6 h, the other group (control group) was procured with volume substitution alone.
Brain-dead organ donors treated at the Department of Emergency Medicine were allocated to the control group, whereas brain-dead organ donors treated in the intensive care unit of the Clinic of Surgery were allocated to the desmopressin group.
Treatment according to protocol was started within 1 h after brain death diagnosis, if diabetes insipidus was evident. Volume substitution was done according to a strict protocol, which was identical for both groups. Adequate fluid substitution was defined as the maintenance of ABP above 80 mmHg, CVP between 8 and 12 mmHg and the achievement of a positive fluid balance of 2000-4000 ml during the overall procurement. Fluid substitution was controlled by continuous measurement of ABP, CVP, and hourly determination of urine output.
Volume substitution was preferably done with hypotonic solutions, i.e. 2.5% glucose, 0.45% sodium chloride. The kind of infusion was determined by the actual serum sodium concentration, i.e. serum sodium > 145 mmol/1, glucose 2.5%; serum sodium < 145 mmol/1, sodium chloride 0.45%. If systolic ABP decreased below 80 mmHg despite a positive fluid balance (2000-4000 ml), inotropic support with dopamine was given. Organ donors receiving more than lOug/kg/min dopamine or other catecholamines as adrenaline and noradrenaline were excluded from further evaluation.
After brain-death diagnosis according to the national legal instructions has been finished, kidneys were retrieved in enbloc method. Kidneys were stored in LTW solution. Recipients were matched with respect to age, sex, HLA-match, cold ischaemic time, current cytotoxic antibodies, and number of prior transplantations. Early renal allograft outcome was determined by daily measurement of serum creatinine, blood urea nitrogen, and urine output within the first 72 h after renal transplantation. After renal transplantation immunosuppressive therapy consisted of prednisolone (2 mg/kg per day tapered to 0.2 mg/kg per day over 1 year) and cyclosporin A (two divided doses to achieve a blood trough level between 250 and 400 ng/ml using polyclonal immunoassay). The first dose of cyclosporin A was given 4 h after the end of transplantation.
Primary non-function of the renal allograft was defined if the transplant recipient remained on haemodialysis treatment during the first 3 days after transplantation. Baseline characteristics of both groups of donors and recipients were compared by the unpaired Student's Mest, y 1 3470+1100 ml, / ) = 0.0007). Time interval from start of brain death diagnosis to retrieval of organs was approximately 14 h (desmopressin group: 14 h (SD 3.2); control group: 13.7 h (SD 4.1). After harvesting, two kidneys from the control group were not used because of cystic alterations. Nine kidneys (control group « = 4; desmopressin group n = 5) had to be excluded from further analysis, as transplantation was performed outside the local centre.
General recipient characteristics
Overall, mean age of all 71 recipients was 48 ±14 years; range 8-71). Causes of renal insufficiency included glomerulonephritis (H=49, 69.0%), analgesic nephropathy (w = 15, 21.1%), pyelonephritis (n = 4, 5.6%); polycystic kidney disease (« = 2, 2.8%), and Wegener disease (« = 1, 1.4%). The majority of kidneys (fl = 56; desmopressin group « = 32; control group n = 24) were transplanted into recipients of first cadaveric transplants. Nine (desmopressin group n = 4; control group n = 5) recipients received their second allograft, five (control group: n = 5) their third one, and one recipient (desmopressin group) his fourth one. Both groups of recipients are comparable with regard to age, sex, cold ischaemic time, number of prior transplantations and current cytotoxic antibodies (Table 2) .
General donor characteristics
Mean age of all 41 donors was 45 ±12 years (range 24-69). Causes of brain death were subarachnoid bleeding (n = 26, 63.4%), intracranial haemorrhage (n= 13, 31.7%), and strangulation (n = 2, 4.8%). Overall, the average dosage of dopamine required was 2.7 ug/kg/min during procurement. Both groups of donors were comparable with respect to age, sex, dosage of dopamine, serum creatinine, and serum sodium prior to explanation ( Table 1 ). The groups did not differ as far as course of arterial blood pressure, central venous pressure, serum sodium, serum osmolarity, and urine output were concerned (Figure 1 ). Fluid balance was positive in both groups of organ donors (desmopressin group 2450 ±650 ml; control group 
Early renal allograft function
Overall, in 26 (36.6%) of 71 recipients non-primary function of the renal allograft was noted. Kidneys removed from donors treated with desmopressin had a significantly higher proportion of primary nonfunction compared to kidneys harvested from the control group (48.6% vs 23.5%; P = 0.028; Table 3 ). The mean serum creatinine on the 3rd day after transplantation was lower in the control group compared to the desmopressin group (3.9 mg/dl (SD 2.9) vs 5.5 mg/dl (SD 3.3); P = 0.03, 95% CI for the difference -3.0 to -0.1).
Discussion
In kidneys harvested from organ donors receiving vasopressin a higher rate of primary non-function was observed compared to kidneys retrieved from donors treated with fluid substitution. The proportion of primary renal allograft failure (48.6%) in the desmopressin group was comparable to earlier data, which demonstrate a similar rate of acute graft failure if the donors received pitressin [6] . Experimental data also indicate that vasopressin induces acute non-oliguric renal failure due to a contraction in glomerular mesangial cells [9] . Furthermore, in experimental settings no spontaneous recovery of vasopressin-injured kidneys occurs. Desmopressin has a significantly higher antidiuretic: vasopressor ratio than vasopressin or pitressin [1] . Therefore the increased rate of primary non-function of renal allografts from desmopressin-treated donors might be due to its increased antidiuretic effect. Therefore the use of desmopressin in organ donor management is questionable. Recent studies in brain death organ donors give evidence for normal vasopressin plasma levels despite the development of diabetes insipidus [10] . Hohenegger et al. also observed a lack of response of urine flow and urine osmolality to exogenous vasopressin [10] . The authors suggested a total to partial insensibility of the distal nephron to vasopressin. In view of these data the substitution of vasopressin or analogues as desmopressin during organ donor management has to be re-evaluated.
Evidently other donor-related factors may also contribute to primary non-function of renal allografts, e.g. age, serum creatinine, mean arterial blood pressure, use of catecholamines [11] [12] [13] . Additionally, recipientrelated factors as age, cold ischaemic time, HLA match, number of prior transplantations, and current cytotoxic antibodies may lead to primary renal allograft non-function [14, 15] . The aforementioned factors were equally distributed in both groups. In contrast, fluid balance was significantly higher in the control group compared to the desmopressin group. Nevertheless, the fluid balance of both groups was within the predefined range (2000-4000 ml). It might be assumed that a better fluid balance in the control group might account for the improved outcome of renal allografts.
The most crucial factor in determining optimal organ viability is still the maintenance of an adequate systemic perfusion pressure. The higher fluid balance of the control group did not affect the haemodynamic parameters of the organ donors, as arterial blood pressure and central venous pressure were nearly identical in both groups during the procurement. Therefore, we do not assume that the higher fluid balance observed in the control group is responsible for the increased rate of primary functioning renal allografts.
In contrast we suggest that desmopressin substitution exerts a negative effect on primary renal allograft function and is mainly responsible for the higher rate of primary non-functioning renal allografts.
Until larger randomized studies concerning the effect of desmopressin on early renal allograft function are available, desmopressin should be used cautiously during organ procurement.
